Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-26

Clinical Trial Update: The Measurement of Insulin Resistance in Peritoneal Dialysis Patients [NA]

View source ↗

Summary

A Vanderbilt University-sponsored study evaluating insulin resistance measurement in peritoneal dialysis patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University | Conditions: End Stage Renal Disease | NA | Status: COMPLETED